Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases-Reference-Cited by-同舟云学术

Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases

Published:2020-10-21 Issue: Volume:2 Page:
ISSN:2673-3129
Container-title:Frontiers in Medical Technology
language:
Short-container-title:Front. Med. Technol.

Author:

Xu Ziyang,Patel Ami,Tursi Nicholas J.,Zhu Xizhou,Muthumani Kar,Kulp Daniel W.,Weiner David B.

Funder

National Institutes of Health

Publisher

Frontiers Media SA

Reference143 articles.

1. Estimating the full public health value of vaccination;Gessner;Vaccine.,2017

2. DNA vaccines: ready for prime time?;Kutzler;Nat Rev Genet.,2008

3. DNA vaccines-how far from clinical use?;Hobernik;Int J Mol Sci.,2018

4. DNA vaccines: prime time is now;Gary;Curr Opin Immunol.,2020

5. Synthetic DNA vaccine strategies against persistent viral infections;Villarreal;Expert Rev Vaccines.,2013

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Importance of the electrophoresis and pulse energy for siRNA-mediated gene silencing by electroporation in differentiated primary human myotubes;BioMedical Engineering OnLine;2024-05-16

2. Poly(I:C) and R848 ligands show better adjuvanticity to induce B and T cell responses against the antigen(s);Heliyon;2024-03

3. DNA Vaccines: Their Formulations, Engineering and Delivery;Vaccines;2024-01-11

4. DNA Vaccines: History, Molecular Mechanisms and Future Perspectives;Journal of Molecular Biology;2023-12

5. Generating and measuring effective vaccine-elicited HIV-specific CD8+ T cell responses;Current Opinion in HIV and AIDS;2023-09-20